MobilEM vs its rivals

Side-by-side comparison against MobilEM's closest competitors — identity, store metrics, ratings & sentiment, and strategic intel.

MobilEM
This App
Kardia
Peer
Core Identity
DeveloperEmergency Medicine Residents' AssociationVargo Anesthesia IncAliveCor, Inc.MediSafe Inc.DoximityInquiry Health LLCSword Health, Inc
CategoryMedicalMedicalMedicalMedicalMedicalMedicalMedical
PlatformiOS, AndroidAndroid, iOSiOS, AndroidiOSAndroid, iOSiOSiOS, Android
Store Metrics
Rating3.6 / 54.7 / 54.8 / 54.7 / 54.8 / 54.8 / 54.7 / 5
Ratings Count38158210,89599,626191,45129,01543,038
PriceFree$99.99FreeFreeFreeFreeFree
Release DateOct 21, 2019Jan 9, 2014Jan 6, 2013Nov 8, 2012Sep 29, 2010Jul 8, 2015Sep 10, 2019
Last UpdatedJan 9, 2026Mar 19, 2026Apr 15, 2026Feb 10, 2026Apr 17, 2026May 12, 2026Apr 11, 2026
Sentiment & Reviews
Sentimentnegative--terrible-positivemixed
Score35/100--25/100-75/10045/100
Praises
  • Comprehensive clinical reference library provides essential medical guidance for emergency department shifts
--
  • Reliable medication reminders provide essential daily support for managing complex health schedules
-
  • Guided audio sessions provide a quiet mental space for users seeking daily habit development
  • Personalized physical therapy programs delivered at home provide measurable pain relief and mobility improvements
Complaints
  • Subscription verification failures prevent users from accessing purchased clinical content after updates
--
  • Frequent application crashes and interface freezes prevent users from logging medication doses
  • Aggressive transition to a paid subscription model locks users out of existing data
-
  • Mobile interface regressions prevent users from interacting with essential buttons on smaller screen sizes
  • Aggressive and invasive communication tactics across multiple channels overwhelm users with excessive notifications and calls
Requests
  • Expansion of clinical content to include pediatric emergency medicine and fundamental guides
----
  • Family sharing support for premium subscriptions to allow access for household members
  • Consolidated device and application usage to eliminate the need for secondary hardware or multiple logins
Strategic Intel
Strengths
  • Evidence-based library functions as a brand-authority moat for clinical reference
  • Note-taking features increase switching costs by tethering user-generated clinical data
  • Niche specialization in anesthesia workflows
  • Offline-first architecture for OR environments
  • One-time purchase model vs. subscriptions
-
  • Clinical-grade drug interaction engine
  • Deep integration with US health infrastructure
  • Multi-user family sync
-
  • Clinical CBT framework provides high-value utility
  • Privacy-first local storage reduces security-related churn
  • AI-driven journaling provides personalized reflection
  • FDA-listed device certification validates clinical efficacy
  • AI-human hybrid model scales therapy access
  • Outcome-based pricing aligns with enterprise cost-reduction
Weaknesses
  • Subscription verification failures post-update drive recurring churn
  • Module-specific crashes in sedation guides erode professional trust
  • High $99.99 upfront cost barrier
  • Static content updates vs. weekly evidence feeds
  • Lack of automated drug dose calculations
-
  • High crash frequency post-update
  • Mandatory paywall for historical data
  • Inconsistent notification reliability
-
  • Interface regressions on smaller screens block workflows
  • Billing transparency issues drive negative sentiment
  • Inconsistent cross-device synchronization
  • Aggressive multi-channel notification intensity
  • Hardware pairing failures in the latest release
  • Multi-step login friction across devices
Pricingfreemiumpaidfreemiumfreemiumfreefreemiumfree
MomentumMaintenanceMaintenanceIntenseActiveIntenseMaintenanceIntense
Update Cadence2 versions, ~2d avg5 versions, ~18d avg5 versions5 versions, ~11d avg5 versions3 versions, ~57d avg5 versions

Compare MobilEM head-to-head

Disclosure: Independent intel to help mobile builders succeed.

AI-powered analysis with editorial review, built from publicly available sources. Marlvel.ai is not affiliated with, endorsed by, or sponsored by MobilEM, its developer, the app publisher, Apple, or Google Play. All trademarks, logos, and screenshots referenced remain the property of their respective owners.

Data licensed under CC-BY-NC 4.0